W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; SYSTEM, ENDO GRAFT, ARTERIOVENOUS DIALYSIS ACCESS CIRCUIT STENOSIS TREATMENT
|
Back to Search Results |
|
Catalog Number JHJR061002J |
Device Problem
Complete Blockage (1094)
|
Patient Problem
Thrombosis/Thrombus (4440)
|
Event Date 09/05/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
Review of device manufacturing record history confirmed device met pre-release specifications.Device remains implanted; therefore, direct product analysis was not possible.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Event Description
|
The following was reported from a study: on (b)(6) 2020, patient presented with a venous stenosis of an arteriovenous graft (unknown manufacturer) located in the basilic vein in the patient¿s right upper arm.During the endovascular treatment, a gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn device) was implanted.The patient tolerated the procedure.On (b)(6) 2020, the viabahn device and the arteriovenous graft were found to be occluded with thrombus.On the same day, a cuff dialysis catheter was implanted in the right internal jugular vein to keep the vascular access circuit.
|
|
Manufacturer Narrative
|
H6.Code 213: sterilization task was completed.A review of the sterilization records indicated the lot met all pre-release specifications.
|
|
Search Alerts/Recalls
|
|
|